vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $123.8M, roughly 1.2× NATURES SUNSHINE PRODUCTS INC). On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 5.1%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
NATR vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $151.1M |
| Net Profit | $4.1M | — |
| Gross Margin | 72.5% | 17.8% |
| Operating Margin | 4.3% | 2.3% |
| Net Margin | 3.3% | — |
| Revenue YoY | 4.7% | 3.6% |
| Net Profit YoY | 1379.4% | — |
| EPS (diluted) | $0.23 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $151.1M | ||
| Q3 25 | $128.3M | $126.8M | ||
| Q2 25 | $114.8M | $132.5M | ||
| Q1 25 | $113.2M | $135.7M | ||
| Q4 24 | $118.2M | $145.8M | ||
| Q3 24 | $114.6M | $122.3M | ||
| Q2 24 | $110.6M | $130.8M | ||
| Q1 24 | $111.0M | $136.8M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $1.6M | ||
| Q2 25 | $5.3M | $-17.2M | ||
| Q1 25 | $4.7M | $7.8M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $4.7M | ||
| Q2 24 | $1.3M | $8.3M | ||
| Q1 24 | $2.3M | $7.1M |
| Q4 25 | 72.5% | 17.8% | ||
| Q3 25 | 73.3% | 15.1% | ||
| Q2 25 | 71.7% | 3.9% | ||
| Q1 25 | 72.1% | 22.0% | ||
| Q4 24 | 72.0% | 22.8% | ||
| Q3 24 | 71.3% | 18.5% | ||
| Q2 24 | 71.4% | 22.3% | ||
| Q1 24 | 71.2% | 21.5% |
| Q4 25 | 4.3% | 2.3% | ||
| Q3 25 | 7.0% | -2.7% | ||
| Q2 25 | 3.7% | -15.6% | ||
| Q1 25 | 5.4% | 6.2% | ||
| Q4 24 | 3.8% | 7.8% | ||
| Q3 24 | 4.6% | 3.1% | ||
| Q2 24 | 5.1% | 6.9% | ||
| Q1 24 | 4.2% | 5.5% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | 1.2% | ||
| Q2 25 | 4.6% | -13.0% | ||
| Q1 25 | 4.2% | 5.7% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | 3.9% | ||
| Q2 24 | 1.2% | 6.3% | ||
| Q1 24 | 2.1% | 5.2% |
| Q4 25 | $0.23 | $0.22 | ||
| Q3 25 | $0.30 | $0.10 | ||
| Q2 25 | $0.28 | $-1.05 | ||
| Q1 25 | $0.25 | $0.46 | ||
| Q4 24 | $-0.02 | $0.62 | ||
| Q3 24 | $0.23 | $0.28 | ||
| Q2 24 | $0.07 | $0.47 | ||
| Q1 24 | $0.12 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $92.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $283.8M |
| Total Assets | $261.1M | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $92.5M | ||
| Q3 25 | $95.6M | $80.8M | ||
| Q2 25 | $81.3M | $101.4M | ||
| Q1 25 | $86.5M | $108.3M | ||
| Q4 24 | $84.7M | $105.5M | ||
| Q3 24 | $78.7M | $96.0M | ||
| Q2 24 | $68.7M | $105.6M | ||
| Q1 24 | $77.8M | $115.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $283.8M | ||
| Q3 25 | $166.7M | $279.6M | ||
| Q2 25 | $163.7M | $289.3M | ||
| Q1 25 | $167.1M | $321.5M | ||
| Q4 24 | $161.0M | $319.6M | ||
| Q3 24 | $162.6M | $314.9M | ||
| Q2 24 | $156.4M | $321.5M | ||
| Q1 24 | $159.7M | $332.0M |
| Q4 25 | $261.1M | $342.0M | ||
| Q3 25 | $264.8M | $342.3M | ||
| Q2 25 | $254.9M | $349.5M | ||
| Q1 25 | $252.7M | $379.0M | ||
| Q4 24 | $240.9M | $384.0M | ||
| Q3 24 | $245.3M | $373.5M | ||
| Q2 24 | $235.8M | $376.7M | ||
| Q1 24 | $247.3M | $385.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $15.5M |
| Free Cash FlowOCF − Capex | $7.6M | $12.3M |
| FCF MarginFCF / Revenue | 6.1% | 8.2% |
| Capex IntensityCapex / Revenue | 1.9% | 2.1% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $15.5M | ||
| Q3 25 | $18.5M | $12.9M | ||
| Q2 25 | $4.3M | $14.7M | ||
| Q1 25 | $2.6M | $11.1M | ||
| Q4 24 | $12.2M | $20.0M | ||
| Q3 24 | $9.6M | $9.4M | ||
| Q2 24 | $1.3M | $18.7M | ||
| Q1 24 | $2.2M | $7.3M |
| Q4 25 | $7.6M | $12.3M | ||
| Q3 25 | $16.8M | $7.0M | ||
| Q2 25 | $3.0M | $9.1M | ||
| Q1 25 | $1.5M | $10.0M | ||
| Q4 24 | $10.0M | $16.4M | ||
| Q3 24 | $7.9M | $2.6M | ||
| Q2 24 | $-2.0M | $10.1M | ||
| Q1 24 | $-1.5M | $5.6M |
| Q4 25 | 6.1% | 8.2% | ||
| Q3 25 | 13.1% | 5.5% | ||
| Q2 25 | 2.6% | 6.9% | ||
| Q1 25 | 1.3% | 7.4% | ||
| Q4 24 | 8.5% | 11.2% | ||
| Q3 24 | 6.9% | 2.1% | ||
| Q2 24 | -1.9% | 7.7% | ||
| Q1 24 | -1.4% | 4.1% |
| Q4 25 | 1.9% | 2.1% | ||
| Q3 25 | 1.3% | 4.6% | ||
| Q2 25 | 1.2% | 4.2% | ||
| Q1 25 | 1.0% | 0.8% | ||
| Q4 24 | 1.9% | 2.5% | ||
| Q3 24 | 1.5% | 5.5% | ||
| Q2 24 | 3.0% | 6.6% | ||
| Q1 24 | 3.3% | 1.3% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 8.15× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 1.98× | ||
| Q2 24 | 0.97× | 2.27× | ||
| Q1 24 | 0.94× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
